Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please accept our Terms & Conditions

We do not show your email or contact info

Please provide email or phone
Please provide email or phone
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Goodbye! and best wishes in your recovery
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Pfizer vaccine, Azusa, CA, USA

3 years ago

Azusa, California, United States

I have had both shots of the Pfizer vaccine. After the first shot I had mild soreness at the injection site. This went away I a day. The second injection was a little more reactive. I had the soreness, but, later in the evening I had mild chills. Which went away in about a hour. That’s it regarding my experiences. | Symptoms: Chills, Soreness

322


Related Reports

I got this covid booster, and flu shot at the same time. Zero side effects so far, and I am on day 3 now. I assume by now I am in the clear. The picture says moderna, but he assured me it was the pfizer. See Less
544


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples. The product lot... See More was distributed nationwide to wholesalers/hospitals in the United States from July 16, 2020 through July 24, 2020. To date, Pfizer has not received reports of any adverse events associated with this issue for this lot.

Risk Statement: Patients receiving the impacted product have a remote probability of experiencing potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial. The NDC, Lot Number, Expiration Date, and Configuration details for Propofol Injectable Emulsion are indicated below.

Product: Configuration/Count Propofol Injectable Emulsion, 100 mL Single Patient Use Glass Fliptop Vial
NDC: Vial: 0409-4699-54 Tray: 0409-4699-24
Lot Number: EA7470
Expiration Date: 01 JUNE 2023
Presentation: 1g/100 mL, Single Patient Use Glass Fliptop Vial
Configuration/Count: Tray of 10 Units

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira, Inc., a Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: August 22, 2022

Source: fda.gov
See Less
303


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a visible particulate observed in a single vial during annual examination of retain... See More samples. The product lot was distributed nationwide to wholesalers/ hospitals/Department of Defense in the United States from June 10, 2020 through June 26, 2020.

The recalled product is:
- Propofol Injectable Emulsion, USP 100 mL Single Patient Use Glass Fliptop Vial, NDC: Vial: 0409-4699-54 Carton: 0409-4699-24, Lot Number: DX9067, Expiration Date Presentation: 01 MAY 2023, Configuration/Count: 1 g/100 mL, Single Patient Use Glass Fliptop Vial Case of 10 Units.

Risk Statement: Patients receiving the impacted product are at risk of experiencing life-threatening adverse clinical effects including but not limited to: blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

To date, Hospira, Inc. has not received reports of any adverse events associated with this issue for this lot. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion, USP is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a single patient use fliptop vial.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should stop use and distribution and quarantine immediately. If you have further distributed the recalled product, to the wholesale or hospital level/institution, please notify any accounts or additional locations which may have received the recalled product from you. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira Inc, A Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: July 13, 2022

Source: fda.gov
See Less
303


Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level.... See More To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. 

Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

These products are indicated for the treatment of hypertension.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The products have a safety profile that has been established over 20 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data. Although long term ingestion of N-nitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication. Patients currently taking the products should consult with their doctor about alternative treatment options.

The NDC, Lot Number, Expiration Date, and Configuration details for these products are indicated in the tables in the link below and photos of the products can be found below. The product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from November 2019 to March 2022.

- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
- quinapril and hydrochlorothiazide tablets, 20/25 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers and distributors with an existing inventory of the lots, listed in the table above, should stop use and distribution and quarantine the product immediately.

If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you.

Company name: Pfizer
Brand name: Accuretic, Greenstone Brand
Product recalled: Accuretic™ (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets
Reason of the recall: Presence of a nitrosamine, N-nitroso-quinapril
FDA Recall date: March 22, 2022

Source: fda.gov
See Less
303


T8CCR 3205(a) - The quality manager is having symptoms and going to work. The supervisors know about this. He is not wearing a mask.

Alleged Hazards: 1, Employees Exposed: 1
Source: Osha.gov | Receipt Date: 2021-09-10 See Less
322


T8CCR 3203 - Unsanitary conditions for employees and patients. T8CCR 3368 - Waiting room & lunch room chairs are filthy. T8CCR 3362 - Cockroaches, lice, bugs infestation. Kittens live on roof. T8CCR 3203(a)(7) - Cleaning and sanitizing performed by someone with no experience. T8CCR 3203 - COVID-19... See More guidelines are not followed.


Source: Osha.gov | Receipt Date: 2020-09-15
See Less
322


T8CCR 3205(c)(10)(B)- An employee got COVID-19 and was notified to stay home for two weeks. When the employee was called to return back to work, when the employee couldn't because people in the employee's household were still infected, the employee was fired.

Alleged Hazards: 1, Employees Exposed:... See More 1
Source: Osha.gov | Receipt Date: 2021-01-04
See Less
322


T8CCR 4208 - Punch presses with no safety guards. T8CCR 3205 - No social distancing. T8CCR 3205 - Employees are not wearing face masks. T8CCR 5141(a) - De-burin dept. no ventilation.

Alleged Hazards: 4, Employees Exposed: 50
Source: Osha.gov | Receipt Date: 2021-01-04 See Less
322


T8CCR 3205 - Face masks are not enforced, no temperature checks. Owner & manager states everyone there has had COVID-19, so face masks are not required. T8CCR 3203(a)(7) - Employees are required to lift 300 lobs vacuum pumps. No heavy lifting equipment provided by employer

Alleged Hazards:... See More 1, Employees Exposed: 35
Source: Osha.gov | Receipt Date: 2021-02-10
See Less
322


Recent Interesting Reports

I went on instagram and there was an ad for natural life having a big sale . I placed my order, But when I got my receipt in my email it was a company called Ultraory . When I looked to see what people said it was... See More a scam company with cheap knockoffs, so I thought oh well I’ll see what kind of clothes I get . After waiting for a month I received a cheap ring from Second Brother in Flashing NY. See Less
6


I did not order this kind of lighter. So I kindly ask for a refund. Please tell me what I need to do? Thank you! Im in Buffalo, NY, USA See Less
1.4K


Yes, I just received a box with 9 individual packets of some kind of lotion in them ( unknown what for) All Chinese writing- no English- never ordered & don’t know what it is !! See Less
368


I received a small, white, bubble pack envelope that had a small container labeled " KETO PURE BIORIBOSE."
I didn't order it, but I was charged $49.00. Any info on this company?
Any way to track them down? See Less
522


I received this package in my mail today and did not order this and don’t know how to send it back or call these people. Can you help me please. See Less
626


I’m an 82 yr old disabled female. I received a small container of powder. I would have never ordered this because I take medications that would be harmful mixed. How did they get my personal information. I know I have been scammed. This is the second bunch... See More of thief’s that have done this. What can I do. I never ordered this I have no receipt pkg says fulfillment lab, it came in my mailbox See Less
523


Re received an item with no packing slip no return address no nothing! I will be turning this address and company into the better be this bro, as this is a scam! I want my money back I want documentation or I will take this to my attorney! See Less
18


Last 30 days